Haemonetics Corporation (HAE)

Operating profit margin

		Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Operating income	US$ in thousands	164,883	156,033	80,750	89,747	103,351
Revenue	US$ in thousands	2,594,610	2,323,320	985,896	860,363	972,079
Operating profit margin		6.35%	6.72%	8.19%	10.43%	10.63%

March 31, 2024 calculation

Operating profit margin = Operating income ÷ Revenue
= $164,883K ÷ $2,594,610K
= 6.35%

The operating profit margin of Haemonetics Corporation has exhibited a declining trend over the past five fiscal years. The margin decreased from 10.63% in March 2020 to 6.35% in March 2024, reflecting a consistent downward trajectory. This decline suggests a reduction in the company's ability to generate profits from its core operations relative to revenue. Factors such as increasing costs, pricing pressures, or operational inefficiencies may have contributed to this downward trend. It is essential for the company to closely monitor and address these issues to sustain or improve its operating profitability in the future.